1 Introduction The importance of understanding the contribution of ethnic differences in drug pharmacokinetics (PK) and how these may impact on dose and drug–drug interaction (DDI) liability is well known [1]. The USA is an increasingly diverse population; latest census data indicates that 57.8% are white, 18.7% Hispanic or Latino, 12.1% African American, and 11.4% other ethnicities [2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Joyce E. M.
Contact Joyce E. M., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack